Growth Metrics

Bruker (BRKRP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to $293.1 million.

  • Bruker's Cash & Equivalents rose 9790.68% to $293.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.1 million, marking a year-over-year increase of 9790.68%. This contributed to the annual value of $183.4 million for FY2024, which is 6244.11% down from last year.
  • Latest data reveals that Bruker reported Cash & Equivalents of $293.1 million as of Q3 2025, which was up 9790.68% from $92.0 million recorded in Q2 2025.
  • Bruker's Cash & Equivalents' 5-year high stood at $1.1 billion during Q4 2021, with a 5-year trough of $92.0 million in Q2 2025.
  • For the 5-year period, Bruker's Cash & Equivalents averaged around $483.8 million, with its median value being $573.0 million (2021).
  • Per our database at Business Quant, Bruker's Cash & Equivalents tumbled by 7047.67% in 2024 and then surged by 9790.68% in 2025.
  • Bruker's Cash & Equivalents (Quarter) stood at $1.1 billion in 2021, then crashed by 39.57% to $645.5 million in 2022, then fell by 24.35% to $488.3 million in 2023, then crashed by 62.44% to $183.4 million in 2024, then surged by 59.81% to $293.1 million in 2025.
  • Its last three reported values are $293.1 million in Q3 2025, $92.0 million for Q2 2025, and $184.2 million during Q1 2025.